Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases
Y Zhang, H Yang, D Wei, X Zhang, J Wang, X Wu… - …, 2021 - Wiley Online Library
Neurodegenerative diseases (NDs) are a class of heterogeneous diseases that includes
Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral …
Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral …
Applications of various types of nanomaterials for the treatment of neurological disorders
Neurological disorders (NDs) are recognized as one of the major health concerns globally.
According to the World Health Organization (WHO), neurological disorders are one of the …
According to the World Health Organization (WHO), neurological disorders are one of the …
Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders
P Chakraborty, A Dey, AV Gopalakrishnan… - Ageing Research …, 2023 - Elsevier
In the mammalian brain, glutamate is regarded to be the primary excitatory neurotransmitter
due to its widespread distribution and wide range of metabolic functions. Glutamate plays …
due to its widespread distribution and wide range of metabolic functions. Glutamate plays …
A sensitive fluorescence sensor based on a glutathione modified quantum dot for visual detection of copper ions in real samples
Z Hu, W Long, T Liu, Y Guan, G Lei, Y Suo, M Jia… - … Acta Part A: Molecular …, 2023 - Elsevier
Abstract Copper (Cu 2+), as a heavy metal, accumulates in the human body to a certain
extent, which can induce various diseases and endanger human health. Rapid and …
extent, which can induce various diseases and endanger human health. Rapid and …
Congo Red‐Derived Carbon Dots: Simultaneously as Fluorescence Probe for Protein Aggregates, Inhibitor for Protein Aggregation, and Scavenger of Free Radicals
The pathological aggregation of some proteins is claimed to be highly related to several
human diseases, such as β‐amyloid 1–42 (Aβ42) to Alzheimer's disease (AD), islet amyloid …
human diseases, such as β‐amyloid 1–42 (Aβ42) to Alzheimer's disease (AD), islet amyloid …
Recent advances in the effective removal of hazardous pollutants from wastewater by using nanomaterials—a review
M Chahar, S Khaturia, HL Singh, VS Solanki… - Frontiers in …, 2023 - frontiersin.org
Environmental nanotechnology has developed rapidly over the past few decades due to the
fast advancement of nanotechnology and nanomaterials (NMs). Due to their nanoscale size …
fast advancement of nanotechnology and nanomaterials (NMs). Due to their nanoscale size …
Antioxidant for neurological diseases and neurotrauma and bioengineering approaches
Antioxidants are a class of molecules with an innate affinity to neutralize reactive oxygen
species (ROS), which are known to cause oxidative stress. Oxidative stress has been …
species (ROS), which are known to cause oxidative stress. Oxidative stress has been …
MoS2 quantum dots based on lipid drug delivery system for combined therapy against Alzheimer's disease
X Qi, P Ye, M Xie - Journal of Drug Delivery Science and Technology, 2023 - Elsevier
Pathological pathways of Alzheimer's disease (AD) are criss-crossed, various pathological
factors are dynamically correlated and relatively independent, which makes the single-target …
factors are dynamically correlated and relatively independent, which makes the single-target …
Nanotheranostics revolutionizing neurodegenerative diseases: From precision diagnosis to targeted therapies
R Joshi, H Missong, J Mishra, S Kaur, S Saini… - Journal of Drug Delivery …, 2023 - Elsevier
Neurodegenerative disorders pose a significant burden on global healthcare systems, and
the development of effective therapeutics and diagnostics remains a critical challenge …
the development of effective therapeutics and diagnostics remains a critical challenge …
Recent progress of small-molecule-based theranostic agents in Alzheimer's disease
F Gao, J Chen, Y Zhou, L Cheng, M Hu… - RSC Medicinal …, 2023 - pubs.rsc.org
Alzheimer's disease (AD) is the most common forms of neurodegenerative dementia. As a
multifactorial disease, AD involves several etiopathogenic mechanisms, in which multiple …
multifactorial disease, AD involves several etiopathogenic mechanisms, in which multiple …